首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1521393

全球听神经瘤市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Acoustic Neuroma Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2032 年，全球听神经瘤市场的市场规模将从 2023 年的 20.4 亿美元达到近 40.6 亿美元，2024-2032 年研究期间复合年增长率为 7.96%。

听神经瘤是一种非癌性生长，发生在第八脑神经上，将内耳直接连接到大脑。这种生长缓慢的肿瘤由雪旺细胞产生，雪旺细胞产生覆盖神经纤维的髓鞘。症状通常包括听力损失、耳鸣（耳鸣）和平衡障碍。在某些情况下，它可能会导致脸部麻木或无力。虽然其确切原因尚不清楚，但遗传因素（例如 2 型神经纤维瘤病 (NF2)）可能会增加风险。治疗方案各不相同，可能包括定期监测、手术切除或放射治疗，取决于肿瘤大小、生长速度和患者整体健康状况等因素。

市场动态

听神经瘤盛行率的增加是推动市场成长的主要因素。随着诊断技术的进步，更多的听神经瘤病例被及早发现，导致对有效治疗的更高需求。微创手术和立体定位放射外科等外科手术的创新显着改善了患者的治疗效果，推动了市场的发展。患者和医疗保健提供者对这种情况及其症状的认识不断提高，导致诊断和介入更加频繁。人口老化是另一个关键因素，因为这种情况更有可能发生在老年人身上。此外，政府对听神经瘤和相关神经系统疾病研究的措施和资助为市场扩张提供了重要动力。研究机构和製药公司合作开发新疗法在推动市场成长方面也发挥着至关重要的作用。医疗保健基础设施投资的增加，特别是在发展中国家，预计将提供新的市场机会。然而，高昂的治疗成本和潜在的副作用可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球听神经瘤市场的每个细分市场进行了包容性评估。听神经瘤产业的成长和趋势为这项研究提供了整体方法。

市场区隔

听神经瘤市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

装置
药物（全身性类固醇、抗病毒药物、血管扩张剂其他）

依疾病类型

传导性听力损失
感音神经性混合性听损失
混合（传导性和感音神经性）

按最终用户

医院
耳科诊所
门诊诊所

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲听神经瘤市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。听神经瘤市场的主要参与者包括F. Hoffmann-La Roche AG、Amgen、Roche、Natus Medical Incorporated、Elekta、Natus Medical Incorporated、辉瑞公司、Civco Medical Solutions、Novartis AG、Maico Diagnostics GmbH、Siemens Healthcare GmbH、 Interacoustics A /S。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：听神经瘤公司的竞争格局

听神经瘤市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
F. Hoffmann-La Roche AG

公司简介
公司收入
产品
最近的发展

Amgen

公司简介
公司收入
产品
最近的发展

Roche

公司简介
公司收入
产品
最近的发展

Natus Medical Incorporated

公司简介
公司收入
产品
最近的发展

Elekta

公司简介
公司收入
产品
最近的发展

Natus Medical Incorporated

公司简介
公司收入
产品
最近的发展

Pfizer Inc.

公司简介
公司收入
产品
最近的发展

Civco Medical Solutions

公司简介
公司收入
产品
最近的发展

Novartis AG

公司简介
公司收入
产品
最近的发展

Maico Diagnostics GmbH

公司简介
公司收入
产品
最近的发展

Siemens Healthcare GmbH

公司简介
公司收入
产品
最近的发展

Interacoustics A/S

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112115228

The global demand for Acoustic Neuroma Market is presumed to reach the market size of nearly USD 4.06 Billion by 2032 from USD 2.04 Billion in 2023 with a CAGR of 7.96% under the study period 2024-2032.

Acoustic neuroma is a non-cancerous growth that arises on the eighth cranial nerve, linking the inner ear directly to the brain. This slow-growing tumor arises from Schwann cells, which produce the myelin sheath covering nerve fibers. Symptoms often include hearing loss, tinnitus (ringing in the ear), and balance disturbances. In some cases, it can cause facial numbness or weakness. While its exact cause is unclear, genetic factors, such as neurofibromatosis type 2 (NF2), can increase the risk. Treatment options vary and can include regular monitoring, surgical removal, or radiation therapy, depending on factors such as the tumor's size, growth rate, and the patient's overall health.

MARKET DYNAMICS

The increasing prevalence of acoustic neuroma is the primary factor driving market growth. With advancements in diagnostic techniques, more cases of acoustic neuroma are being detected early, leading to higher demand for effective treatments. Innovations in surgical procedures, such as minimally invasive surgeries and stereotactic radiosurgery, have significantly improved patient outcomes, boosting the market. The rising awareness among patients and healthcare providers about this condition and its symptoms has led to more frequent diagnoses and interventions. The aging population is another critical factor, as this condition is more likely to develop in older adults. Furthermore, government initiatives and funding for research into acoustic neuroma and related neurological conditions provide a significant impetus for market expansion. Collaboration between research institutions and pharmaceutical companies to develop novel therapies also plays a crucial role in driving market growth. Rising investment in healthcare infrastructure, especially in developing countries, is expected to provide new market opportunities. However, the high cost of treatment and potential side effects may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Acoustic Neuroma. The growth and trends of Acoustic Neuroma industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Acoustic Neuroma market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Devices
Drugs (Systemic Steroids, Antiviral Medicatior, Vasodilators Others)

By Disease Type

Conductive Hearing Loss
Sensorineural Hearing Loss Mixed
Mixed (Conductive And Sensorineural)

By End-User

Hospitals
Otology Clinics
Ambulatory Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Acoustic Neuroma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Acoustic Neuroma market include F. Hoffmann-La Roche AG, Amgen, Roche, Natus Medical Incorporated, Elekta, Natus Medical Incorporated, Pfizer Inc., Civco Medical Solutions, Novartis AG, Maico Diagnostics GmbH, Siemens Healthcare GmbH, Interacoustics A/S. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ACOUSTIC NEUROMA - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Disease Type
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ACOUSTIC NEUROMA MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Devices Historic and Forecast Sales By Regions
5.4. Drugs (Systemic Steroids, Antiviral Medicatior, Vasodilators Others) Historic and Forecast Sales By Regions

6. GLOBAL ACOUSTIC NEUROMA MARKET ANALYSIS BY DISEASE TYPE

6.1. Overview By Disease Type
6.2. Historical and Forecast Data Analysis By Disease Type
6.3. Conductive Hearing Loss Historic and Forecast Sales By Regions
6.4. Sensorineural Hearing Loss Mixed Historic and Forecast Sales By Regions
6.5. Mixed (Conductive And Sensorineural) Historic and Forecast Sales By Regions

7. GLOBAL ACOUSTIC NEUROMA MARKET ANALYSIS BY END-USER

7.1. Overview By End-User
7.2. Historical and Forecast Data Analysis By End-User
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Otology Clinics Historic and Forecast Sales By Regions
7.5. Ambulatory Clinics Historic and Forecast Sales By Regions

8. GLOBAL ACOUSTIC NEUROMA MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ACOUSTIC NEUROMA COMPANIES

9.1. Acoustic Neuroma Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ACOUSTIC NEUROMA INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. F. Hoffmann-La Roche AG
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Amgen
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Roche
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Natus Medical Incorporated
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Elekta
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Natus Medical Incorporated
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Pfizer Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Civco Medical Solutions
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Novartis AG
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Maico Diagnostics GmbH
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Siemens Healthcare GmbH
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Interacoustics A/S
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Devices Market Sales By Geography (USD MN)
Drugs (Systemic Steroids, Antiviral Medicatior, Vasodilators Others) Market Sales By Geography (USD MN)
Analysis By Disease Type (USD MN)
Conductive Hearing Loss Market Sales By Geography (USD MN)
Sensorineural Hearing Loss Mixed Market Sales By Geography (USD MN)
Mixed (Conductive And Sensorineural) Market Sales By Geography (USD MN)
Analysis By End-User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Otology Clinics Market Sales By Geography (USD MN)
Ambulatory Clinics Market Sales By Geography (USD MN)
Global Acoustic Neuroma Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Acoustic Neuroma Report
Market Research Process
Market Research Methodology
Global Acoustic Neuroma Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Disease Type
Market Attractiveness Analysis By End-User
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Devices Market Sales By Geography (USD MN)
Drugs (Systemic Steroids, Antiviral Medicatior, Vasodilators Others) Market Sales By Geography (USD MN)
Global Market Analysis By Disease Type (USD MN)
Conductive Hearing Loss Market Sales By Geography (USD MN)
Sensorineural Hearing Loss Mixed Market Sales By Geography (USD MN)
Mixed (Conductive And Sensorineural) Market Sales By Geography (USD MN)
Global Market Analysis By End-User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Otology Clinics Market Sales By Geography (USD MN)
Ambulatory Clinics Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis